Resource library

Videos

Videos

START & MEDIAN Technologies partnership on imaging in oncology trials (short version)

Dr. Tony Tolcher from START on MEDIAN Technologies: Image Interpretation and Management in Oncology Clinical Trials.
Run time: 00:30

20 November 2016

START & MEDIAN Technologies partnership on imaging in oncology trials (short version)

Dr. Tony Tolcher from START on MEDIAN Technologies: Image Interpretation and Management in Oncology Clinical Trials. Run time: 00:30

START & MEDIAN Technologies partnership on imaging in oncology clinical trials (long version)

START are accelerating the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer. Their drug development program is not only furthering cancer research, but also offers hope to patients facing the toughest cancer battles. In this video Dr. Tony Tolcher from START talks about the importance of Median Technologies to their mission.
Run time: 02:41

1 September 2016

START & MEDIAN Technologies partnership on imaging in oncology clinical trials (long version)

START are accelerating the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer. Their…

Learn more about Median Technologies’ difference for image interpretation and management in oncology trials

Run time: 06:54

18 April 2016

Learn more about Median Technologies’ difference for image interpretation and management in oncology trials

Run time: 06:54

Dr. Souhil Zaim, Medical Director, Median Technologies about imaging in immuno-oncology clinical trials

Dr. Souhil Zaim, Medical Director, Median Technologies talks about the important differences in imaging for immuno-oncology clinical trials – both early and late phase. Dr. Zaim was interviewed during the Immunotherapy World conference, January 25-27, 2016 – Washington DC, USA.
Run time: 03:53

23 March 2016

Dr. Souhil Zaim, Medical Director, Median Technologies about imaging in immuno-oncology clinical trials

Dr. Souhil Zaim, Medical Director, MEDIAN Technologies on the important differences in imaging for immuno-oncology clinical trials – both early and late phase.

Resource library

Cookies help us deliver our services. By using our services, you agree to our use of cookies.